NM_002982.4:c.*65C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002982.4(CCL2):​c.*65C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 923,064 control chromosomes in the GnomAD database, including 45,576 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6917 hom., cov: 32)
Exomes 𝑓: 0.30 ( 38659 hom. )

Consequence

CCL2
NM_002982.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.224

Publications

57 publications found
Variant links:
Genes affected
CCL2 (HGNC:10618): (C-C motif chemokine ligand 2) This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020]
CCL2 Gene-Disease associations (from GenCC):
  • neural tube defects, susceptibility to
    Inheritance: AD Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCL2NM_002982.4 linkc.*65C>T 3_prime_UTR_variant Exon 3 of 3 ENST00000225831.4 NP_002973.1 P13500

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCL2ENST00000225831.4 linkc.*65C>T 3_prime_UTR_variant Exon 3 of 3 1 NM_002982.4 ENSP00000225831.4 P13500
CCL2ENST00000624362.2 linkn.1608C>T non_coding_transcript_exon_variant Exon 1 of 1 6
CCL2ENST00000580907.6 linkc.*549C>T 3_prime_UTR_variant Exon 2 of 2 2 ENSP00000462156.1 J3KRT7

Frequencies

GnomAD3 genomes
AF:
0.287
AC:
43568
AN:
151918
Hom.:
6905
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.202
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.282
Gnomad EAS
AF:
0.555
Gnomad SAS
AF:
0.342
Gnomad FIN
AF:
0.344
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.275
Gnomad OTH
AF:
0.285
GnomAD4 exome
AF:
0.298
AC:
229448
AN:
771026
Hom.:
38659
Cov.:
10
AF XY:
0.298
AC XY:
119827
AN XY:
402548
show subpopulations
African (AFR)
AF:
0.191
AC:
3682
AN:
19294
American (AMR)
AF:
0.512
AC:
16349
AN:
31906
Ashkenazi Jewish (ASJ)
AF:
0.281
AC:
5496
AN:
19542
East Asian (EAS)
AF:
0.619
AC:
21702
AN:
35060
South Asian (SAS)
AF:
0.334
AC:
21294
AN:
63754
European-Finnish (FIN)
AF:
0.343
AC:
17258
AN:
50330
Middle Eastern (MID)
AF:
0.281
AC:
1207
AN:
4292
European-Non Finnish (NFE)
AF:
0.258
AC:
131757
AN:
509932
Other (OTH)
AF:
0.290
AC:
10703
AN:
36916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
7261
14521
21782
29042
36303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2914
5828
8742
11656
14570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.287
AC:
43608
AN:
152038
Hom.:
6917
Cov.:
32
AF XY:
0.296
AC XY:
21971
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.202
AC:
8389
AN:
41448
American (AMR)
AF:
0.431
AC:
6582
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.282
AC:
979
AN:
3470
East Asian (EAS)
AF:
0.555
AC:
2870
AN:
5170
South Asian (SAS)
AF:
0.343
AC:
1652
AN:
4814
European-Finnish (FIN)
AF:
0.344
AC:
3635
AN:
10566
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.275
AC:
18685
AN:
67982
Other (OTH)
AF:
0.284
AC:
600
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1561
3122
4684
6245
7806
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
7358
Bravo
AF:
0.290
Asia WGS
AF:
0.440
AC:
1529
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.8
DANN
Benign
0.63
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13900; hg19: chr17-32583911; COSMIC: COSV56773543; COSMIC: COSV56773543; API